Tuesday, May 18, 2021

Sanofi-GSK COVID vax shows strong immune responses in Phase 2 trial

A COVID-19 vaccine developed by pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) has shown strong rates of neutralising antibody responses against the infectious Coronavirus disease in the Phase-II trial.

from Zee News :Zee News - Health https://ift.tt/3hyEotX
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Ozempic Launches In India: Doctors Reveal Weight Loss Benefits, Risks, And Who Can Use It

Ozempic has officially arrived in India at a comparatively affordable price, sparking buzz among diabetes and weight loss patients alike. Ex...